Federal Circuit Expedites Key Patent Dispute Over COVID-19 Vaccine Innovations Involving Moderna and Arbutus Biopharma
The Federal Circuit has agreed to expedite proceedings in a contentious patent case concerning COVID-19 vaccines, involving biotechnology giants Moderna Inc. and Arbutus Biopharma Corp. The accelerated timeline means that oral arguments will happen in November, a decision that reflects the ongoing sensitivity and urgency of patent disputes in the realm of pandemic-related innovations. The…